Document:

<Page>

                                                                   EXHIBIT 10(o)

                              EMPLOYMENT AGREEMENT

     AGREEMENT dated as of this 1st day of November, 2001, by and between CANTEL
MEDICAL CORP., a Delaware corporation (the "Company"), and CRAIG A. SHELDON (the
"Employee").

                                  INTRODUCTION

     Employee is currently employed as Vice President and Chief Financial
Officer of the Company. Employee and the Company desire to enter into an
employment agreement and to set forth herein the terms and conditions of
Employee's employment by the Company.

     NOW, THEREFORE, in consideration of the mutual covenants herein contained,
it is hereby agreed by and between the Company and Employee as follows:

     1.   ENGAGEMENT AND TERM. The Company hereby employs Employee and Employee
hereby accepts such employment by the Company on the terms and conditions set
forth herein, for the period commencing on November 1, 2001 (the "Effective
Date") and ending, unless sooner terminated in accordance with the provisions of
Section 4 hereof, on October 31, 2004 (the "Employment Period"). As used in this
Agreement, the term "Contract Year" shall refer to each twelve-month period
during the Employment Period ending October 31.

<Page>

     2.   SCOPE OF DUTIES. Employee shall be employed by the Company as its
Vice President and Chief Financial Officer. In such capacities, Employee shall
have such authority, powers and duties customarily attendant upon such offices.
If elected or appointed, Employee shall also serve, without additional
compensation, in one or more offices and, if and when elected, as a director of
the Company or any subsidiary or affiliate of the Company, provided that his
duties and responsibilities are not inconsistent with those pertaining to his
position as stated above. Employee agrees to perform the duties associated with
his employment to the best of his abilities, and shall faithfully devote his
full business time and efforts so as to advance the best interests of the
Company. During the Employment Period, Employee shall not be engaged in any
other business activity, whether or not such business activity is pursued for
profit or other pecuniary advantage, unless otherwise approved in writing by the
Board of Directors of the Company.

     3.   COMPENSATION.

          3.1  BASE SALARY. In respect of services to be performed by Employee
during the Employment Period, the Company agrees to pay Employee a base salary
("Base Salary") at the rate of $175,000 per annum during the initial Contract
Year, payable in accordance with the Company's customary payroll practices for
executive employees.

               The Base Salary shall be increased annually by an amount
established by reference to the "Consumer Price Index for Urban Wage Earners and
Clerical Workers, New York, New York, all items "Series A-01" published by the
Bureau of Labor Statistics of the United States Department of Labor (the
"Consumer Price Index"). The base period shall be the month ended September 30,
2001 (the "Base Period"). If the Consumer Price Index for the month of September
in any year, commencing in 2002, is greater than the Consumer Price Index for
the Base Period, then the Base Salary shall be increased, commencing on November
1 of the next Contract Year, to the amount obtained by multiplying Base Salary
by a fraction, the numerator of which is the Consumer Price Index for the month
of September of the year in which shall determination is being made and the
denominator of which is the

                                        2
<Page>

Consumer Price Index for the Base Period. Notwithstanding the foregoing, in no
event shall Employee receive, for any Contract Year, an increase in Base Salary
of less than five (5%) percent over the Base Salary, as adjusted for the
previous Contract Year.

          3.2  BONUS. Employee shall be entitled to an annual Bonus determined
each year by the Compensation Committee of the Board of Directors of the Company
based on Employee's performance and such other factors that the Committee deems
appropriate.

          3.3  DISCRETIONARY COMPENSATION. Employee shall also be entitled to
such additional increases in Base Salary, bonuses and stock options as may be
determined from time to time by the Compensation Committee of the Board of
Directors of the Company.

          3.4  LIFE INSURANCE. Provided that Employee is insurable at rates that
are comparable to those obtainable on other persons of similar age and position
in good health (if Employee is classified in a higher risk category, he may
elect to pay the excess premium cost to obtain the coverage), during the
Employment Period the Company shall procure and maintain term life insurance on
the life of Employee in the face amount of $175,000. Employee shall be the owner
of such life insurance policy and shall have the absolute right to designate the
beneficiaries thereunder. The Company shall pay all premiums for such life
insurance. Employee agrees to submit to all medical examinations, supply all
information and execute all documents required by insurance companies in
connection with the issuance of such policy.

          3.5  USE OF AUTOMOBILE. During the Employment Period, Employee shall
be entitled to the use of an automobile leased or owned by the Company in
connection with the Company's business. The make and model of the automobile
shall be reasonably satisfactory to Employee, provided that the Company's
monthly payments in respect thereof (exclusive of the expenses referred to in
the following sentence) shall not exceed $500. Employee shall be entitled to
receive reimbursement for reasonable out-of-pocket expenses, including, without
limitation, cost of gas, oil, insurance and other

                                        3
<Page>

costs incurred by Employee in operating and maintaining the automobile;
provided, however, that Employee shall be responsible for keeping appropriate
records regarding the use of said automobile, as instructed by the Company or
its accountants.

          3.6  OTHER BENEFITS.

               3.6.1     During the Employment Period, Employee shall be
entitled to participate, at Company expense (subject to applicable employee
contribution requirements imposed by the Company from time to time on its
employees generally), in the medical health insurance plan, and all other
health, insurance and other benefit plans applicable generally to executive
officers of the Company on the same basis as such officers. In addition,
Employee shall be entitled to participate in the Company's 401(k) benefit plan.

               3.6.2     During the Employment Period, Employee will be entitled
to paid vacation (four weeks) and holidays consistent with the Company's policy
applicable to executives generally. All vacations shall be scheduled at the
mutual convenience of the Company and Employee.

               3.6.3     The Company will reimburse Employee for reasonable
out-of-pocket expenses incurred in furtherance of the business of the Company,
including travel, entertainment and similar items, upon the presentation of
appropriate receipts or vouchers therefor, consistent with the Company's policy
applicable to executives generally.

     4.   TERMINATION OF EMPLOYMENT. The provisions of Section 1 of this
Agreement notwithstanding, this Agreement and Employee's employment hereunder
may be terminated in the manner and for the causes hereinafter set forth, in
which event the Company shall be under no further obligation to Employee other
than as specifically provided herein:

                                        4
<Page>

          4.1  If Employee is absent from work or otherwise substantially
unable to assume his normal duties for a period of sixty (60) successive days or
an aggregate of ninety (90) business days during any consecutive twelve-month
period during the Employment Period because of physical or mental disability,
accident, illness, or any other cause other than vacation or approved leave of
absence, the Company may thereupon, or any time thereafter will such absence or
disability still exists, terminate the employment of Employee hereunder upon ten
(10) days' written notice to Employee.

          4.2  In the event of the death of Employee, this Agreement shall
immediately terminate on the date thereof.

          4.3  If Employee materially breaches or violates any material term of
his employment hereunder, or commits any criminal act or an act of dishonesty or
moral turpitude, in the reasonable judgment of the Company's Board of Directors,
then the Company may, in addition to other rights and remedies available at law
or equity, immediately terminate this Agreement upon written notice to Employee
with the date of such notice being the termination date and such termination
being deemed for "cause."

          4.4  Employee may terminate his employment under this Agreement upon
not less than thirty (30) days' written notice to the Company if the Company,
without Employee's consent, undergoes a "Change in Control" (as defined below).
"Change in Control" shall mean (1) the acquisition of beneficial ownership,
direct or indirect, of securities of the Company by any person (as that term is
defined in Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as
amended), other than Employee or a person approved by Employee, which when
combined with all other securities of the Company beneficially owned, directly
or indirectly, by that person, equals or exceeds 50% of the combined voting
power of the Company's then outstanding securities or (2) at any time after the
Effective Date, a majority of the Board of Directors is composed of persons who
are not "Continuing Directors" as hereinafter defined. "Continuing Directors" as
used herein shall mean (i) the directors of the Company at the close of business
on the Effective Date, and (ii) any person who was or is elected (A) to succeed
a

                                        5
<Page>

Continuing Director or (B) to become a director as a result of an increase in
the size of the board, recommended, in each case, by a majority of the
Continuing Directors then on the Board. Any Termination Notice given by Employee
hereunder must be given within ninety (90) days following the occurrence of the
event giving rise to such termination.

          4.5  In the event Employee's employment shall be terminated by reason
of the provisions of Section 4.1 or 4.2, then in such event, the Company shall
continue to pay to Employee, if living, or other person or persons as Employee
may from time to time designate in writing as the beneficiary of such payments,
the Basic Compensation in effect at the time which such death or disability
occurred during the three-month period following such death or disability.

          4.6  Upon termination of Employee's employment under Section 4.3, the
Company shall have no further obligation under this Agreement to make any
payments to Employee or to bestow any benefits on Employee after the termination
date, other than payments and benefits accrued and due and payable to Employee
prior to the termination date.

          4.7  Upon termination of Employee's employment by Employee under
Section 4.4, then in addition to payments and benefits accrued and due and
payable to Employee prior to the termination date, the Company shall pay to
Employee in a lump sum, within ten (10) days following the termination date, an
amount equal to one hundred fifty percent (150%) of the Base Salary and
Incentive Compensation paid by the Company to Employee for the most recently
completed Contract Year.

          4.8  Upon termination of Employee's employment under Sections 4.1, 4.2
or 4.4, then in addition to the payments and benefits payable to Employee
specified above, the Company agrees that for a period of ninety (90) days
following such termination it will (i) in the case of termination under Section
4.1 or 4.4, continue Employee's coverage under the Company's medical health
insurance plan provided under Section 3.6.1 above (directly or through the
payment of all applicable amounts under COBRA) or, (ii) in the event of
termination under Section 4.2, pay the cost of family coverage (for Employee's
wife and children) under a medical health insurance plan having benefits similar
to those in

                                        6
<Page>

effect under the Company's medical health insurance plan in effect at the time
of termination.

     5.   DISCLOSURE OF CONFIDENTIAL INFORMATION, ASSIGNMENT OF INVENTIONS, AND
          COVENANTS NOT TO COMPETE.

          5.1  CONFIDENTIAL INFORMATION. Employee acknowledges that the Company
(which term, for purposes of Section 5 shall be deemed to include Carsen Group
Inc., MediVators, Inc., Minntech Corporation, and other affiliates of the
Company) possesses confidential information, know-how, customer lists,
purchasing, merchandising and selling techniques and strategies, and other
information used in its operations of which Employee has or will obtain
knowledge, and that the Company will suffer serious and irreparable damages and
harm if this confidential information were disclosed to any other party or if
Employee used this information to compete against the Company. Accordingly,
Employee hereby agrees that except as required by Employee's duties to the
Company, Employee, without the consent of the Company's Board of Directors,
shall not at any time during or after the Employment Period disclose or use any
secret or confidential information of the Company, including, without
limitation, such business opportunities, customer lists, trade secrets,
formulas, techniques and methods of which Employee shall become informed during
his employment, whether learned by him as an employee of the Company, as a
member of its Board of Directors or otherwise, and whether or not developed by
Employee, unless such information shall be or becomes public knowledge other
than as a result of Employee's direct or indirect disclosure of the same.

                                        7
<Page>

          5.2  PATENT AND RELATED MATTERS.

               5.2.1     Employee will promptly disclose in writing to the
Company complete information concerning each and every invention, discovery,
improvement and idea (whether or not shown or described in writing or reduced to
practice), and device, design, apparatus, process, and work of authorship,
whether or not patentable, copyrightable or registerable, which is made,
developed, perfected, devised, conceived or first reduced to practice by
Employee, either solely or in collaboration with others, during the Employment
Period, whether or not during regular working hours (hereinafter collectively
referred to as the "Inventions"). Employee, to the extent that he has the legal
right to do so, hereby acknowledges that any and all of the Inventions are
property of the Company and hereby assigns and agrees to assign to the Company
any and all of Employee's right, title and interest in and to any and all of the
Inventions.

               5.2.2     LIMITATION. It is further agreed and Employee is hereby
notified that the above agreement to assign the Inventions to the Company does
not apply to an Invention for which no equipment, supplies, facility or
confidential information of the Company was used and which was developed
entirely on Employee's own time, and

                           (i)     which does not relate (a) directly to the
business of the Company or (b) to the Company's actual or demonstrably
anticipated research or development, or

                                        8
<Page>

                           (ii)    which does not result from any work performed
by Employee for the Company.

               5.2.3     ASSISTANCE. Upon request and without further
compensation therefor, but at no expense to Employee, and whether during the
Employment Period or thereafter, Employee will do all lawful acts, including,
but not limited to, the execution of documents and instruments and the giving of
testimony, that in the opinion of the Company, its successors and assigns, may
be necessary or desirable in obtaining, sustaining, reissuing, extending or
enforcing United States and foreign copyrights and Letters Patent, including,
but not limited to, design patents, on any and all of the Inventions, and for
perfecting, affirming and recording the Company's complete ownership and title
thereto, and to cooperate otherwise in all proceedings and matters relating
thereto.

               5.2.4     RECORDS. Employee will keep complete, accurate and
authentic accounts, notes, data and records of all the Inventions in the manner
and form requested by the Company. Such accounts, notes, data and records shall
be the property of the Company, and upon its request, Employee will promptly
surrender the same to it.

               Upon the termination of his employment hereunder, Employee agrees
to deliver promptly to the Company all records, manuals, books, blank forms,
documents, letters, memoranda, notes, notebooks, reports, data, tables,
accounts, calculations and copies thereof, which are the property of the Company
or which relate in any way to the business, products, practices or techniques of
the Company, and all other property, trade secrets and confidential information
of the Company, including, but not limited to, all documents which in whole or
in part contain any trade secrets or confidential information of the Company,
which in any of these cases are in his possession or under his control.

                                        9
<Page>

          5.3  NON-COMPETE. Employee agrees that for a period of twenty-four
(24) months following the termination of Employee's employment hereunder, except
as a result of the breach by the Company of any material term or condition
hereof, Employee will not, directly or indirectly, alone or with others,
individually or through or by a corporate or other business entity in which he
may be interested as a partner, shareholder, joint venturer, officer, director,
employee or otherwise, own, manage, control, participate in, lend his name to,
or render services to or for any business within the continental United States
or Canada which is competitive with that of the Company or any of its
affiliates, provided, however, that the foregoing shall not be deemed to prevent
the ownership by Employee of up to five (5%) percent of any class of securities
of any corporation which is regularly traded on any stock exchange or
over-the-counter market. For the purpose of this Agreement, a business activity
competitive with the business of the Company or any of its affiliates shall
include only the design, manufacture, marketing, sale, or distribution of (i)
endoscopes, (ii) endoscope disinfection or sterilization equipment or supplies,
(iii) infection control equipment, products, supplies or systems or (iv)
products or services for the dialysis, medical device reprocessing, or
filtration and separation markets (collectively "Products") which are the same
as or similar to or compete with, or have a usage allied to Products being
developed, marketed, sold or distributed by the Company or any of its affiliates
at any time during the last twelve months of Employee's employment by the
Company.

                                       10
<Page>

          5.4  NON-INTERFERENCE. Employee further agrees that for a period of
two years following termination of Employee's employment hereunder, he will not
(i) induce or attempt to induce any other employee of the Company or any of its
affiliates to leave the employ of the Company or affiliate, or in any way
interfere with the relationship between the Company (or any of its affiliates)
and any other employee, or (ii) induce or attempt to induce any customer,
supplier, franchisee, licensee, distributor or other business relation of the
Company or any of its affiliates to cease doing business with the Company or
affiliate, or in any way interfere with the relationship between any customer,
franchisee or other business relation and the Company and any of its affiliates
without prior written consent of the Board of Directors of the Company.

          5.5  ENFORCEMENT. If, at the time of enforcement of any provisions of
this Section, a court of competent jurisdiction holds that the restrictions
stated herein are unreasonable under the circumstances then existing, the
parties hereto agree that the maximum period, scope or geographical area
reasonable under such circumstances will be substituted for the stated period,
scope or area. Employee agrees that the covenants made in this Section shall be
construed as an agreement independent of any other provision of this Agreement,
and shall survive the termination of this Agreement.

     6.   MISCELLANEOUS PROVISIONS.

          7.1  Section headings are for convenience only and shall not be deemed
to govern, limit, modify or supersede the provisions of this Agreement.

          7.2  This Agreement is entered into in the State of New Jersey and
shall be governed pursuant to the laws of the State of New Jersey. If any
provision of this Agreement shall be held by a court of competent jurisdiction
to be invalid, illegal or unenforceable, the remaining provisions hereof shall
continue to be fully effective.

          7.3  This Agreement contains the entire agreement of the parties
regarding this subject matter. There are no contemporaneous oral agreements, and
all prior understandings, agreements, negotiations and representations are
merged herein.

                                       11
<Page>

          7.4  This Agreement may be modified only by means of a writing signed
by the party to be charged with such modification.

          7.5  Notices or other communications required or permitted to be given
hereunder shall be in writing and shall be deemed duly given upon receipt by the
party to whom sent at the respective addresses set forth below or to such other
address as any party shall hereafter designate to the other in writing delivered
in accordance herewith:

          If to the Company:
               Cantel Medical Corp.
               150 Clove Road
               Little Falls, NJ 07424

          If to Employee:
               Craig A. Sheldon
               4 Tower Hill Rd.
               Morris Plains, NJ 07950

          7.6  This Agreement shall inure to the benefit of, and shall be
binding upon, the Company, its successors and assigns, including, without
limitation, any entity that may acquire all or substantially all of the
Company's assets and business or into which the Company may be consolidated or
merged. This Agreement may not be assigned by Employee.

          7.7  This Agreement may be executed in separate counterparts and may
be delivered by facsimile, each of which shall constitute the original hereof.

          IN WITNESS WHEREOF, the parties have set their hands as of the date
first above written.

                                              CANTEL MEDICAL CORP.

                                              By: /s/ James P. Reilly
                                                  -------------------

                                              /s/ Craig A. Sheldon
                                              --------------------
                                                 Craig A. Sheldon

                                       12<Page>

                                                                  EXHIBIT 10(gg)

                    THIRD AMENDMENT TO DISTRIBUTION AGREEMENT
                   OLYMPUS AMERICA INC. AND CARSEN GROUP INC.

THIRD AMENDMENT ("Amendment") to Distribution Agreement ("Agreement") between
OLYMPUS AMERICA INC., a New York, U.S.A. corporation having its principal office
at Two Corporate Center Drive, Melville, New York, U.S.A. 11747-3157, and CARSEN
GROUP INC., a Canadian corporation having its principal office at 151 Telson
Road, Markham, Ontario, Canada L3R 1E7. Capitalized terms used but not otherwise
defined in this Amendment shall have the meanings ascribed to such terms in the
Agreement.

WHEREAS, Olympus and Carsen entered into the Agreement as of April 1, 1994; and

WHEREAS, by way of an initial amendment dated August 26, 1997 (the "Initial
Amendment") Olympus and Carsen extended the Term of the Agreement until March
31, 2001 and otherwise amended the Agreement as set forth in the Initial
Amendment; and

WHEREAS, by the way of a further amendment dated October 6, 2000 (the "Second
Amendment", and together with the Initial Amendment, collectively, the "Prior
Amendments") Olympus and Carsen extended the Term of the Agreement until March
31, 2004 and otherwise amended the Agreement as set forth in the Second
Amendment; and

WHEREAS, Olympus and Carsen wish to further amend the Agreement and the Prior
Amendments by, among other things, removing Industrial Products from the
Agreement as hereinafter set forth;

NOW, THEREFORE, for good and adequate consideration, receipt of which is hereby
acknowledged, the parties hereby agree as follows:

1.   Section 1.6 (Industrial Products) and Schedule 1.6 (Industrial Products) of
the Agreement shall be deleted in their entirety along with all related
references to Section 1.6 and Schedule 1.6 throughout the Agreement.

2.   Except for purposes of interpretation of this Amendment, the phrase
"INDUSTRIAL PRODUCTS" shall be deleted from Section 1.10 (Products), Section 3.4
(Marketing), Section 3.7 (Monthly Sales Activity and Inventory Report), Section
5.1 (Order Estimates), Section 5.3.1 (Minimum Purchase Requirements), and
Section 9.1.1 (Term) of the Agreement.

3.   Section 5.3.3 of the Agreement shall be re-written as follows:
          "5.3.3    IF FOR ANY REASON, INCLUDING BUT NOT LIMITED TO FAILURE TO
MEET OLYMPUS'S CREDIT REQUIREMENTS FOR CONTINUED SALE ON OPEN ACCOUNT, CARSEN
COMMITS AN MDPR FAILURE, IN ANY FISCAL PERIOD, FOR: (a) PRECISION PRODUCTS,
OLYMPUS MAY, UPON THIRTY (30) DAYS' WRITTEN NOTICE TO CARSEN WITHIN SIX (6)
MONTHS OF SUCH DEFAULT, TERMINATE THIS AGREEMENT WITH RESPECT TO PRECISION
PRODUCTS OR MAKE ANY OTHER ALTERNATIVE DISTRIBUTION ARRANGEMENTS (INCLUDING
WITHOUT LIMITATION APPOINTING ADDITIONAL DISTRIBUTORS FOR PRECISION PRODUCTS);
AND/OR (b) MEDICAL

<Page>

PRODUCTS, OLYMPUS MAY, UPON THIRTY (30) DAYS' WRITTEN NOTICE TO CARSEN WITHIN
SIX (6) MONTHS OF SUCH DEFAULT, (i) TERMINATE THIS AGREEMENT WITH RESPECT TO
MEDICAL PRODUCTS, OR (ii) TERMINATE THIS AGREEMENT ENTIRELY, OR (iii) MAKE ANY
OTHER ALTERNATIVE DISTRIBUTION ARRANGEMENTS (INCLUDING WITHOUT LIMITATION
APPOINTING ADDITIONAL DISTRIBUTORS FOR MEDICAL PRODUCTS). NOTWITHSTANDING THE
FOREGOING, CARSEN SHALL NOT BE LIABLE FOR DAMAGES IN THE EVENT OF AN MDPR
FAILURE. IN THE EVENT OLYMPUS APPOINTS AN ADDITIONAL DISTRIBUTOR FOR ANY PRODUCT
GROUP (AS SET FORTH ABOVE), THEN THE MINIMUM DOLLAR PURCHASE REQUIREMENTS FOR
THAT PRODUCT GROUP WILL NO LONGER BE APPLICABLE."

4.   Schedule 5.3 (Minimum Dollar Purchase Requirements) of the Agreement shall
be amended by deleting the Industrial Product Minima. Moreover, the Industrial
Product Minimum for the period from April 1, 2000 to March 31, 2001 (i.e.,
133P), set forth in the Initial Amendment as $1,850,000, shall be reduced to
$1,400,000.

5.   Section 6.1 (Patents and Trademarks) of the Agreement shall be amended by
deleting the phrase "AND IN ACCORD WITH THE INSTRUCTIONS ATTACHED HERETO AS
EXHIBIT 6.1".

6.   Section 9.1.1 (Term) shall be re-written as follows:
"THIS AGREEMENT SHALL REMAIN IN FULL FORCE AND EFFECT UNTIL MARCH 31, 2004 (THE
"INITIAL TERM"). THE INITIAL TERM WILL BE EXTENDED BEYOND MARCH 31, 2004 FOR AN
ADDITIONAL TWO-YEAR PERIOD THROUGH MARCH 31, 2006 (THE "RENEWAL PERIOD" AND
TOGETHER WITH THE INITIAL TERM, COLLECTIVELY, THE "TERM"), PROVIDED THAT CARSEN
HAS NOT BREACHED THIS AGREEMENT IN ACCORDANCE WITH SECTION 9.1.2. MOREOVER, IF
CARSEN COMMITS AN MDPR FAILURE WITH RESPECT TO A PRODUCT GROUP IN ANY FISCAL
PERIOD OF THE INITIAL TERM, OLYMPUS SHALL HAVE THE RIGHT TO REMOVE SUCH PRODUCT
GROUP FROM THIS AGREEMENT FOR THE RENEWAL PERIOD OR MAKE ANY OTHER ALTERNATIVE
DISTRIBUTION ARRANGEMENTS WITH RESPECT TO SUCH PRODUCT GROUP (INCLUDING WITHOUT
LIMITATION APPOINTING ADDITIONAL DISTRIBUTORS) DURING THE RENEWAL PERIOD.
MINIMUM DOLLAR PURCHASE REQUIREMENTS FOR EACH YEAR OF THE POTENTIAL RENEWAL
PERIOD SHALL BE MUTUALLY AGREED-UPON, IN GOOD FAITH, BY THE PARTIES. EXCEPT AS
SET FORTH IN THE PRECEDING SENTENCES, NO ACT OF OR OMISSION BY OLYMPUS OR CARSEN
SHALL BE DEEMED TO RESULT IN ANY EXTENSION OF THIS AGREEMENT BEYOND THE INITIAL
TERM UNLESS OLYMPUS AND CARSEN AGREE, BY A WRITTEN INSTRUMENT EXECUTED BY AN
AUTHORIZED OFFICER OF EACH COMPANY, TO EXTEND THE INITIAL TERM."

7.   Olympus's acceptance of Carsen's purchase orders or payments for Industrial
Products after the execution date of this Amendment shall not operate as a
renewal or novation of the Agreement with respect to Industrial Products.

8.   This Amendment may be executed in counterparts, each of which when so
executed shall be deemed to be an original and both of which when taken together
shall constitute one and the same instrument.

9.   As used in this Amendment, the term "Agreement" shall mean the Agreement as
previously amended by the Initial Amendment and the Second Amendment.

Except as modified by this Amendment, the Agreement (as previously amended)
remains unchanged and in full force and effect.

                                        2
<Page>

IN WITNESS WHEREOF, the parties have executed this Amendment to the Agreement as
of the 1st day of April, 2001.

CARSEN GROUP INC.                            OLYMPUS AMERICA INC.

By:  /s/ William Vella                              By: /s/ F. Mark Gumz
     -----------------                                 ----------------
Name:  William Vella                         Name:  F. Mark Gumz
Title: President                             Title: President and COO

                                        3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}]]